WELLS FARGO & COMPANY/MN - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$794,000
-78.3%
23,021
-89.5%
0.00%
-100.0%
Q2 2020$3,662,000
+22.8%
219,169
+5.9%
0.00%0.0%
Q1 2020$2,983,000
-62.9%
206,875
-13.9%
0.00%
-50.0%
Q4 2019$8,046,000
+145.7%
240,395
+53.7%
0.00%
+100.0%
Q3 2019$3,275,000
+186.3%
156,416
+184.8%
0.00%
Q2 2019$1,144,000
-21.7%
54,925
-15.9%
0.00%
Q1 2019$1,461,000
-18.7%
65,339
-13.1%
0.00%
-100.0%
Q4 2018$1,798,000
+6.9%
75,203
+21.9%
0.00%
Q3 2018$1,682,000
+0.2%
61,680
-1.2%
0.00%
Q2 2018$1,679,000
-22.4%
62,445
-8.1%
0.00%
-100.0%
Q1 2018$2,163,000
-9.4%
67,954
+7.6%
0.00%0.0%
Q4 2017$2,388,000
+57.2%
63,158
+3.1%
0.00%
Q3 2017$1,519,000
+24.7%
61,266
+3.4%
0.00%
Q2 2017$1,218,000
-7.0%
59,241
-1.7%
0.00%
Q1 2017$1,309,000
+0.5%
60,240
-5.4%
0.00%
Q4 2016$1,302,000
+58.0%
63,688
+15.9%
0.00%
Q3 2016$824,000
+47.7%
54,933
+6.7%
0.00%
Q2 2016$558,000
-24.7%
51,479
-5.9%
0.00%
Q1 2016$741,000
+497.6%
54,692
+715.4%
0.00%
Q4 2015$124,000
+74.6%
6,707
+136.2%
0.00%
Q3 2015$71,0002,8390.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 414,500$14,280,00013.67%
Burrage Capital Management LLC 332,546$11,456,0009.04%
Penn Mutual Asset Management, LLC 158,783$5,470,0007.72%
First Trust Capital Management L.P. 525,598$18,107,0004.87%
GARDNER LEWIS ASSET MANAGEMENT L P 653,711$22,520,0004.08%
ALPINE ASSOCIATES MANAGEMENT INC. 2,075,100$71,488,0003.76%
S. MUOIO & CO. LLC 90,000$3,101,0003.52%
EQUITEC PROPRIETARY MARKETS, LLC 124,700$4,296,0003.27%
GABELLI & Co INVESTMENT ADVISERS, INC. 501,719$17,284,0003.11%
WATER ISLAND CAPITAL LLC 1,062,245$36,594,0003.11%
View complete list of AIMMUNE THERAPEUTICS INC shareholders